Vesper Healthcare Acquisition Corp

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: BLS Investor Group
IPO Size: $400M
Underwriters: Goldman Sachs
J.P. Morgan Securities
Focus: Healthcare, Pharmaceuticals
SEC Filings: 1818093
Public Embarc Page: https://embarc.com/capital/spac/1818093/VSPR/vesper-healthcare-acquisition
IPO Ticker: VSPR

SPAC Leadership

Information on the SPAC leadership.

President, Chief Executive Officer and Chairman of the Board of DirectorsBrenton L. Saunders
Chief Financial Officer and DirectorManisha Narasimhan
DirectorMichael D. Capellas
DirectorJulius Few
DirectorBarry S. Sternlicht
Brenton Saunders(Fmr CEO, Allergan, Fmr CEO, Bausch + Lomb)
Michael Capellas(Fmr CEO, First Data, Fmr CEO, Compaq, Board Director, Cisco)
Barry Sternlicht(CEO, Starwood Capital)

Target Information

Information on the SPAC target for merger.

Company: HydraFacial
Presentation: Investor Presentation (SEC) on 2020-12-08
New Ticker: SKIN
Description: HydraFacial is "a category-creating beauty health company"that "offers an effective, experiential, non-invasive and accessible skin treatment experience."